Increased epithelial permeability in pulmonary fibrosis in relation to disease progression
Nicole Goh(Royal Brompton Hospital), A.U. Wells(Royal Brompton Hospital), Rachel K. Hoyles(Royal Brompton Hospital), CP Denton(The Royal Free Hospital), Sujal R. Desai(Royal Brompton & Harefield NHS Foundation Trust), C. M. Black(Merck & Co., Inc., Rahway, NJ, USA (United States)), D.M. Hansell(Bispebjerg Hospital), Constantinos Anagnostopoulos(Fondazione Toscana Gabriele Monasterio), R M du Bois(National Jewish Health), Hikari Sato(Royal Brompton Hospital)
Cited by 47
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study
|The Lancet Respiratory Medicine|2016|448
Detection of Significant Coronary Artery Disease by Noninvasive Anatomical and Functional Imaging
|Circulation Cardiovascular Imaging|2015|412